<DOC>
	<DOCNO>NCT01755416</DOCNO>
	<brief_summary>Hypothesis : In type 1 diabetes mellitus , set close loop glucose control system : adjunctive therapy Liraglutide afford well post-prandial glycemic excursion insulin mono-therapy . Specific Aim : To determine post-prandial glucose excursion lower addition Liraglutide compare insulin mono-therapy . Study Design : This randomized open label crossover design trial compare adjuvant Liraglutide insulin Vs. insulin mono-therapy use ePID closed-loop system insulin delivery .</brief_summary>
	<brief_title>Liraglutide Versus Insulin Mono-therapy Closed Loop Setting</brief_title>
	<detailed_description>After screen visit , subject randomize come two overnight visit . Study A- subject close loop device Novolog rapid act insulin . In Study B- addition insulin subject take one time sub cutaneous injection 1.2 mg Victoza dinner Day 1 . Both visit last approximately 30 hour subject manage closed loop device approximately 25 hour .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Age great 18 year less 40 year Have diabetes least 1 year , good control ( HbA1C &lt; 8.5 % ) Be continuous subcutaneous insulin infusion use insulin pump Menstruating woman must negative pregnancy test . Hemoglobin ( Hb ) &gt; 12 g/dL Either treat stable treatment regimen follow medication minimum 3 month prior Screening : . Oral contraceptive ( female subject ) b. Antihypertensive agent c. Lipidlowering agent d. Thyroid replacement therapy e. Antidepressant agent For female subject : . Not breastfeed b . Negative pregnancy test result ( human chorionic gonadotropin , beta subunit [ Î²hCG ] ) Screening c. If childbearing potential , must practice willing continue practice appropriate birth control ( define least one method result low failure rate , i.e. , less 1 % per year , use consistently correctly , implant , injectable 's , hormonal contraceptive , intrauterine contraceptive device , sexual abstinence , tubal ligation occlusion , vasectomized partner ) entire duration study must plan conceive Should alcohol drug dependency assess CRAFFT questionnaire . Any chronic disease ( leukemia , asthma , inflammatory bowel disease , cystic fibrosis , juvenile rheumatoid arthritis , etc. , directly , result treatment , directly indirectly affect glucose homeostasis Hemoglobin le 12 g/dl Positive pregnancy test menstruate young woman Evidence history chemical abuse HbA1c &gt; 8.5 % Weight le 50 Kg History gastro paresis medication alter gastric empty History Pancreatitis impair renal function Hypoglycemic unawareness History sensitivity 5HT3 receptor antagonist History QT prolongation know cardiovascular disease Concomitant use Acetaminophen vitamin C Patients glucocorticoid therapy Known allergy Liraglutide Personal family history elevate calcitonin , calcitonin &gt; 100 ng/L , medullary thyroid carcinoma patient Multiple Endocrine Neoplasia ( MEN ) syndrome type 2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>close loop</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>insulin</keyword>
	<keyword>victoza</keyword>
	<keyword>liraglutide</keyword>
</DOC>